相似文献
1
Invasive aspergillosis after pandemic (H1N1) 2009.
Emerg Infect Dis. 2010 Jun;16(6):971-3. doi: 10.3201/eid1606.100165.
2
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Mycoses. 2012 Mar;55(2):189-92. doi: 10.1111/j.1439-0507.2011.02051.x. Epub 2011 Oct 18.
3
[Invasive pulmonary aspergillosis in an immunocompetent patient presenting with influenza infection].
Med Mal Infect. 2019 Jun;49(4):291-292. doi: 10.1016/j.medmal.2019.01.004. Epub 2019 Jan 29.
4
Influenza A (H1N1) in a pediatric patient with newly diagnosed acute promyelocytic leukemia and invasive pulmonary aspergillosis.
J Pediatr Hematol Oncol. 2011 Oct;33(7):562-4. doi: 10.1097/MPH.0b013e31821ed3d4.
5
Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients.
Clin Infect Dis. 2011 Sep;53(6):e16-9. doi: 10.1093/cid/cir485.
6
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.
Infez Med. 2020 Jun 1;28(2):263-267.
7
[Invasive pulmonary aspergillosis in influenza].
Ned Tijdschr Geneeskd. 2015;159:A7431.
8
Invasive pulmonary aspergillosis associated with influenza.
JAMA. 1979 Apr 6;241(14):1493-4.
9
Invasive pulmonary aspergillosis in the ICU: an emerging disease?
Intensive Care Med. 2013 Apr;39(4):790. doi: 10.1007/s00134-012-2809-4. Epub 2013 Jan 22.
10
Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature.
Expert Rev Respir Med. 2015 Feb;9(1):89-96. doi: 10.1586/17476348.2015.996132. Epub 2014 Dec 30.
引用本文的文献
1
Recent developments in research: diversity, drugs, and disease.
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001123. doi: 10.1128/mmbr.00011-23. Epub 2025 Feb 10.
2
Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study.
Mycopathologia. 2025 Jan 21;190(1):16. doi: 10.1007/s11046-025-00928-8.
3
Fungal lung disease.
Eur Respir J. 2024 Nov 28;64(5). doi: 10.1183/13993003.00803-2024. Print 2024 Nov.
4
IFN Receptor 2 Regulates TNF-α-Mediated Damaging Inflammation during Aspergillus Pulmonary Infection.
J Immunol. 2024 Oct 15;213(8):1202-1211. doi: 10.4049/jimmunol.2200686.
5
Multiple infections secondary to immunosuppression after Chlamydia psittaci infection: a case report.
BMC Infect Dis. 2024 Jul 30;24(1):752. doi: 10.1186/s12879-024-09663-9.
6
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
BMC Infect Dis. 2024 Apr 11;24(1):392. doi: 10.1186/s12879-024-09283-3.
7
Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study.
Open Forum Infect Dis. 2024 Jan 9;11(2):ofae012. doi: 10.1093/ofid/ofae012. eCollection 2024 Feb.
8
Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and community-acquired pneumonia: A prospective observational study.
Curr Med Mycol. 2022 Jun;8(2):16-24. doi: 10.18502/cmm.8.2.10328.
9
Influenza vaccination is associated with a reduced risk of invasive aspergillosis in high-risk individuals in Taiwan: a population-based cohort study.
Emerg Microbes Infect. 2023 Dec;12(1):2155584. doi: 10.1080/22221751.2022.2155584.
10
A Rare Case of Mandibular Osteomyelitis in an Immunocompetent Patient.
Dent J (Basel). 2022 Nov 9;10(11):213. doi: 10.3390/dj10110213.
本文引用的文献
1
Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.
J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii11-ii24. doi: 10.1093/jac/dkq012.
2
Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.
Clin Infect Dis. 2010 Mar 15;50(6):850-9. doi: 10.1086/650581.
3
Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.
JAMA. 2009 Nov 4;302(17):1896-902. doi: 10.1001/jama.2009.1583.
4
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.
JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12.
5
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258.
6
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.
Eur Respir J. 2007 Oct;30(4):782-800. doi: 10.1183/09031936.00062206.
7
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693.
8
Invasive aspergillosis in critically ill patients without malignancy.
Am J Respir Crit Care Med. 2004 Sep 15;170(6):621-5. doi: 10.1164/rccm.200401-093OC. Epub 2004 Jun 30.
9
Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha.
J Immunol. 2002 Dec 1;169(11):6193-201. doi: 10.4049/jimmunol.169.11.6193.
10
Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF.
Thorax. 1999 Nov;54(11):1047-9. doi: 10.1136/thx.54.11.1047.
Zotero 插件